Who will take Korean distribution licenses for Sovaldi and Harvoni?
The pharmaceutical distribution industry has shown high interests in the Korean distribution licenses of chronic hepatitis C treatments, ‘Sovaldi’ and ‘Harvoni’ that are indicated as products with extremely low margins, making more deficits as selling them.
This is because the distribution agree...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
